Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial

被引：8
|
作者：
Fjorden, Karin [1 ]
Ekberg, Sara [2 ]
Kuric, Nevzeta [3 ]
Smedby, Karin E. [4 ,5 ]
Lagerlof, Ingemar [6 ]
Larsen, Thomas S. [7 ]
Jorgensen, Judit M. [8 ]
de Nully Brown, Peter [9 ]
Jerkeman, Mats [1 ]
机构：
[1] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden
[2] Karolinska Inst, Dept Med Solna, Div Clin Epidemiol, Stockholm, Sweden
[3] Halmstad Cty Hosp, Dept Hematol, Halmstad, Sweden
[4] Karolinska Inst, Div Hematol, Dept Med Solna, Stockholm, Sweden
[5] Karolinska Univ Hosp, Stockholm, Sweden
[6] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden
[7] Odense Univ Hosp, Dept Haematol, Odense, Denmark
[8] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
[9] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 196卷 / 02期
关键词：
Idelalisib; relapsed; refractory DLBCL; transformed lymphoma; IBRUTINIB;
D O I：
10.1111/bjh.17792
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 440
页数：4
相关论文
共 50 条
  • [41] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [42] Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Shingleton, Jennifer R.
    Dave, Sandeep S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 166 - +
  • [43] Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Barca, Eva Gonzalez
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [44] ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphoma
    Alderuccio, Juan Pablo
    Sharman, Jeff P.
    BLOOD REVIEWS, 2022, 56
  • [45] Efficacy and safety of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
    Habermann, T.
    Lossos, I.
    Justice, G.
    Tuscano, J.
    Cole, C.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 150 - 150
  • [46] Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease
    Matasar, Matthew J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1327 - 1330
  • [47] The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma
    Rushton, Christopher
    Alcaide, Miguel
    Cheung, Matthew
    Michaud, Neil R.
    Daigle, Scott
    Rys, Ryan N.
    Arthur, Sarah E.
    Zrymiak, Marquisa
    Davidson, Jordan
    Bushell, Kevin R.
    Yu, Stephen
    Jain, Michael D.
    Shepherd, Lois E.
    Marra, Marco A.
    Kuruvilla, John
    Crump, Michael
    Mann, Koren Kathleen
    Assouline, Sarit E.
    Connors, Joseph M.
    Steidl, Christian
    Johnson, Nathalie A.
    Scott, David W.
    Morin, Ryan D.
    BLOOD, 2020, 136
  • [48] Ibrutinib in Combination with R-Gemox-D in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Phase II Clinical Trial of the Geltamo Group
    Bua, Beatriz Rey
    Ubieto, Ana Jimenez
    Blanco, Jose Javier Sanchez
    Abrisqueta, Pau
    Gutierrez, Antonio
    Payer, Angel Ramirez
    Gine, Eva
    Cebeiro, Izaskun, Sr.
    Terol, Maria Jose
    De la Cruz, Fatima
    Andreu, Rafael
    Sanchez, Maria Jose Ramirez
    de la Fuente, Adolfo
    Viguria, Ma Cruz
    Penarrubia, Maria Jesus
    Grande, Carlos
    Caballero, Dolores
    Garcia-Sancho, Alejandro Martin
    BLOOD, 2020, 136
  • [49] Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial
    Riihijarvi, Sari
    Fiskvik, Idun
    Taskinen, Minna
    Vajavaara, Heli
    Tikkala, Maria
    Yri, Olav
    Karjalainen-Lindsberg, Marja-Liisa
    Delabie, Jan
    Smeland, Erlend
    Holte, Harald
    Leppa, Sirpa
    HAEMATOLOGICA, 2015, 100 (02) : 238 - 245
  • [50] Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group
    Papageorgiou, ES
    Tsirigotis, P
    Dimopoulos, M
    Pavlidis, N
    Fountzilas, G
    Papageorgiou, S
    Economopoulos, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (02) : 124 - 129
12345